Roche presents five-year survival outcomes for Tecentriq plus chemotherapy in ES-SCLC
IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Extensive-stage Small cell Lung Cancer
Roche’s Atezolizumab receives DCGI approval for small cell lung cancer treatment in India
Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of ES-SCLC when given…